Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus

AIMS: LY2963016 (LY IGlar) and Lantus (IGlar) are insulin glargine products manufactured by distinct processes, but with identical amino acid sequences. This study compared the duration of action of LY IGlar and IGlar in subjects with type 1 diabetes mellitus (T1DM). MATERIALS AND METHODS: This was...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Obes Metab
Autors principals: Linnebjerg, Helle, Lam, Eric Chen Quin, Zhang, Xin, Seger, Mary E., Coutant, David, Chua, Laiyi, Kapitza, Christoph, Heise, Tim
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2016
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5215447/
https://ncbi.nlm.nih.gov/pubmed/27484286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12759
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars